RKO細胞 
	
		運輸方式:	凍存運輸
	
	
		生長狀態:	貼壁生長
	
	
		ATCC Number:	CRL-2577?
	
	
		相關**:	腫瘤
	
	
		細胞形態:	上皮樣
	
	
		數量:	大量
	
	
		器官來源:	結腸
	
	
		是否是腫瘤細胞:	0
	
	
		物種來源:	人
	
	
		Designations:	RKO
	
	
		Depositors:	 MC Hollander, AJ Fornace
	
	
		RKO細胞Biosafety Level:	1
	
	
		Shipped:	frozen
	
	
		Medium & Serum:	See Propagation
	
	
		Growth Properties:	adherent
	
	
		Organism:	Homo sapiens deposited as human
	
	
		Morphology:	epithelial
	
	
		
	
	
		Source:	Organ: colon
	
	
		Disease: carcinoma
	
	
		Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
	
	
		Receptors:	urokinase receptor (u-PAR) [51462]
	
	
		Tumorigenic:	Yes
	
	
		Oncogene:	p53 + (wild type)
	
	
		DNA Profile (STR):	Amelogenin: X
	
	
		CSF1PO: 8, 10
	
	
		D13S317: 8, 11
	
	
		D16S539: 12, 13
	
	
		D5S818: 11, 13
	
	
		D7S820: 8, 10
	
	
		RKO細胞THO1: 6, 10
	
	
		TPOX:11
	
	
		vWA: 15, 16, 17
	
	
		Comments:	RKO is a poorly differentiated colon carcinoma cell line developed by Michael Brattain.
	
	
		RKO cells contain wild-type p53 but lack endogenous human thyroid receptor nuclear receptor (h-TRbeta1). The level of p53 protein is higher in RKO (ATCC CRL-2577) cells than in RKO-E6 (ATCC CRL-2578) cells. [53331]
	
	
		The RKO cell line is the parental cell line (isogenic) of RKO-E6 (ATCC CRL-2578) and RKO-A545-1 (ATCC CRL-2579). It can be used as the control cell line for investigating the effects of p53 and gadd45 on cellular parameters.
	
	
		Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Eagle's Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
	
	
		Temperature: 37.0°C
	
	
		Atmosphere: air, 95%; carbon dioxide (CO2), 5%
	
	
		Subculturing:	Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:12 is recommended
	
	
		Medium Renewal: Every 2 to 3 days
	
	
		Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. RKO細胞Allow the flask to sit at room temperature (or at 37C) until the cells detach.
	
	
		Add fresh culture medium, aspirate and dispense into new culture flasks.
	
	
		Preservation:	culture medium 95%; DMSO, 5%
	
	
		Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2003
	
	
		recommended serum:ATCC 30-2020
	
	
		derivative:ATCC CRL-2578
	
	
		derivative:ATCC CRL-2579
	
	
		References:	51462: Boyd D, et al. Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines. Cancer Res. 48: 3112-3116, 1988. PubMed: 2835152
	
	
		51463: Smith ML, et al. Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 10: 1053-1059, 1995. PubMed: 7700629
	
	
		53329: Brattain MG, et al. Heterogeneity of human colon carcinoma. Cancer Metastasis Rev. 3: 177-191, 1984. PubMed: 6437669
	
	
		53331: Bhat MK, et al. RKO細胞Tumor suppressor p53 is a negative regulator in thyroid hormone receptor signaling pathways. J. Biol. Chem. 272: 28989-28993, 1997. PubMed: 9360971